US 11993573
Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents
granted A61KA61K31/352A61K31/382
Quick answer
US patent 11993573 (Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents) held by The Board of Regents for Oklahoma State University expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents for Oklahoma State University
- Grant date
- Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/352, A61K31/382, A61K31/47, A61P